News

Share
27th November 2015
12:23pm GMT

The drug, Daraprim. (Source:WSLS10)
Shkreli then proceeded to hike up the price of the drug to a massive $750 per pill from a previous $13.50.
He was widely criticised for the move by politicians and medical professionals, and made a promise to lower to price of the drug back down but he had not specified an amount.
The company has now stated that the price of the pills for patients will stay the same, with a reduction in price for hospitals only.
Chief commercial officer Nancy Retzlaff said: “Drug pricing is one of the most complex parts of the healthcare industry. A drug’s list price is not the primary factor in determining patient affordability and access.
Another US pharmaceutical company, Imprimis Pharmaceuticals has however introduced an alternative drug that will sell for $1 per pill.(The Washington Post)
(Featured Image: The Independent)
Explore more on these topics:

Health
health